Concept Multidisciplinaire richtlijn Stoornissen in ... - GGZ-richtlijnen

het totale behandelpakket . Er zijn echter geen studies beschikbaar waarin wordt gekeken
naar de rol van deze medicamenteuze interventie bij de totstandkoming van het effect van
CRA.
5
10
15
20
25
30
35
Literatuur
• Anton RF, Moak DH, Waid LR, Latham PK, Malcolm RJ, Dias JK. Naltrexone and cognitive behavioral
therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial. Am J Psychiatry
1999; 156(11):1758-64.
• Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, Gastfriend DR, Hosking JD,
Johnson BA, LoCastro JS, Longabaugh R, Mason BJ, Mattson ME, Miller WR, Pettinati HM, Randall CL,
Swift R, Weiss RD, Williams LD, Zweben A. COMBINE Study Research Group. Combined pharmacotherapies
and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled
trial. JAMA. 2006 3;295(17):2003-17
• Feeney GF, Young RM, Connor JP, Tucker J, McPherson A. Cognitive behavioural therapy combined
with the relapse-prevention medication acamprosate: are short-term treatment outcomes for alcohol dependence
improved? Aust N Z J Psychiatry. 2002;36(5):622-8.
• Hammarberg A, Wennberg P, Beck O, Franck J. A comparison of two intensities of psychosocial intervention
for alcohol dependent patients treated with acamprosate.Alcohol Alcohol. 2004;39(3):251-5.
• Pelc I, Ansoms C, Lehert P, Fischer F, Fuchs WJ, Landron F, Pires Preto AJ, Morgan MY. (2002)The
European NEAT program: an integrated approach using acamprosate and psychosocial support for the
prevention of relapse in alcohol-dependent patients with a statistical modeling of therapy success prediction.
Alcoholism, Clinical And Experimental Research. 26 (10);1529-38.
• Pelc I, Hanak C, Baert I, Houtain C, Lehert P, Landron F, Verbanck P. Effect of community nurse followup
when treating alcohol dependence with acamprosate. Alcohol Alcohol. 2005;40(4):302-7.
• Pettinati HM, Volpicelli JR, Pierce JD Jr; O'Brien CP. Improving naltrexone response: an intervention for
medical practitioners to enhance medication compliance in alcohol dependent patients. Journal Of Addictive
Diseases 2000;19 (1);71-83.
• Roozen HG, de Waart R, van der Windt DA, van der Brink W, de Jong CA, Kerkhof AJ. A systematic review
of the effectiveness of naltrexone in the maintenance treatment of opioid and alcohol dependence.
Eur Neuropsychopharmacol. 2006;16(5):311-23.
• Reid SC, Teesson M, Sannibale C, Matsuda M, Haber PS. The efficacy of compliance therapy in pharmacotherapy
for alcohol dependence: a randomized controlled trial. J Stud Alcohol. 2005;66(6):833-41
• Soyka M, Preuss U, Schuetz C. Use of acamprosate and different kinds of psychosocial support in relapse
prevention of alcoholism. Results from a non-blind, multicentre study. Drugs R D. 2002;3(1):1-12.
• Wildt, WAJM. de, Schippers GM, Brink W van den, Potgieter AS, Deckers F, Bets D. Does psychosocial
treatment enhance the efficacy of acamprosate in patients with alcohol problems? Alcohol and Alcoholism,2002
37;375-382.
Concept multidiscipliniare richtlijn stoornissen in het gebruik van alcohol, 2007 107